ME01147B - Biciklični derivati morfin-6-glukuronida, njihovo dobijanje i primjena u terapiji - Google Patents

Biciklični derivati morfin-6-glukuronida, njihovo dobijanje i primjena u terapiji

Info

Publication number
ME01147B
ME01147B MEP-2011-104A MEP10411A ME01147B ME 01147 B ME01147 B ME 01147B ME P10411 A MEP10411 A ME P10411A ME 01147 B ME01147 B ME 01147B
Authority
ME
Montenegro
Prior art keywords
compound
group
general formula
accordance
preparation
Prior art date
Application number
MEP-2011-104A
Other languages
English (en)
Inventor
Alain Dlubala
Isabelle Ripoche
Claire Trecant
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ME01147B publication Critical patent/ME01147B/me

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06—Heterocyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)

Abstract

Ovaj pronalazak se odnosi na jedinjenja koja odgovaraju formuli (I)     u kojoj : R 1  predstavlja atom vodonika ili grupu (C 1 -C 4 )alkil, R 2  predstavlja hidroksilnu grupu, tiol grupu, grupu (C 1 -C 4 )alkiloksi ili grupu tio(C 1 -C 4 )alkil, i n je celi broj 1 ili 2, u obliku baze ili adici one soli sa kiselinom kao i u obliku hidrata ili solvata. Ovaj pronalazak takođe obuhvata postupak njihovog dobijanja i terapeutsku primenu.

Claims (6)

1.Jedinjenje opšte formule (I) (I) u kojoj : R1 predstavlja atom vodonika ili grupu (C1-C4)alkil, R2 predstavlja hidroksilnu grupu, tiol grupu, grupu (C1-C4)alkiloksi ili grupu tio(C1-C4)alkil i n je ceo broj 1 ili 2, u obliku baze baze ili adicione soli kiseline kao i u obliku hidrata ili solvata.
2.Jedinjenje opšte formule (I) u skladu sa zahtevom 1, naznačeno time, što pomenuto jedinjenje ima jednu ili više sledećih karakteristika : -R1 je vodonikov atom, -R2 je hidroksi grupa; i -n je 2.
3.Jedinjenje opšte formule (I) u skladu sa zahtevom 1 ili 2, naznačeno time, što pomenuto jedinjenje je morfin-6-il 5-C-(5-hidroksi-4,5,6,7-tetrahidro[1,2,4]triazolo[1,5-a]pirimidin-2-il)- beta-D-ksilopiranozid.
4.Lek, naznačen time, što sadrži jedinjenje opšte formule (I) u skladu sa nekim od zahteva 1 do 3, ili adicionu so ovog jedinjenja sa framakološki prihvatljivom kiselinom, ili još neki hidrat ili solvat jedinjenja formule (I).
5.Farmaceutski oblik, naznačen time, što sadrži jedinjenje opšte formule (I) u skladu sa nekim od zahteva 1 do 3, ili neku farmaceutski prihvatljivu so, kao i bar jedan ekcipijent farmakološki prihvatljiv.
6.Upotreba jedinjenja opšte formule (I) u skladu sa nekim od zahteva 1 do 3 za pripremu leka namenjenog za tretman ili za prevenciju bola.
MEP-2011-104A 2008-12-11 2009-12-08 Biciklični derivati morfin-6-glukuronida, njihovo dobijanje i primjena u terapiji ME01147B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0806974A FR2939796B1 (fr) 2008-12-11 2008-12-11 Derives bicycliques de morphine-6-glucuronide, leur preparation et leur application en therapeutique
EP09801747.8A EP2376511B1 (fr) 2008-12-11 2009-12-08 Derives bicycliques de morphine-6-glucuronide, leur preparation et leur application en therapeutique
PCT/FR2009/052446 WO2010067008A2 (fr) 2008-12-11 2009-12-08 Derives bicycliques de morphine-6-glucuronide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
ME01147B true ME01147B (me) 2012-12-20

Family

ID=41037668

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2011-104A ME01147B (me) 2008-12-11 2009-12-08 Biciklični derivati morfin-6-glukuronida, njihovo dobijanje i primjena u terapiji

Country Status (32)

Country Link
US (1) US8440634B2 (me)
EP (1) EP2376511B1 (me)
JP (1) JP5616355B2 (me)
KR (1) KR20110091536A (me)
CN (1) CN102317302B (me)
AR (1) AR074578A1 (me)
AU (1) AU2009326907B2 (me)
BR (1) BRPI0923368A2 (me)
CA (1) CA2746701A1 (me)
CL (1) CL2011001401A1 (me)
CO (1) CO6382159A2 (me)
CR (1) CR20110317A (me)
EA (1) EA201170791A1 (me)
EC (1) ECSP11011107A (me)
ES (1) ES2470684T3 (me)
FR (1) FR2939796B1 (me)
HN (1) HN2011001614A (me)
IL (1) IL213380A (me)
MA (1) MA32954B1 (me)
ME (1) ME01147B (me)
MX (1) MX2011006251A (me)
MY (1) MY153779A (me)
NI (1) NI201100113A (me)
NZ (1) NZ593340A (me)
PE (1) PE20120231A1 (me)
SG (1) SG172070A1 (me)
SV (1) SV2011003937A (me)
TN (1) TN2011000277A1 (me)
TW (1) TW201026313A (me)
UA (1) UA104445C2 (me)
WO (1) WO2010067008A2 (me)
ZA (1) ZA201104389B (me)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766188A (en) 1971-06-28 1973-10-16 Yamanouchi Pharma Co Ltd Carbonyldioxymorphinan derivatives
GB9116909D0 (en) 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
GB2282758A (en) 1993-08-23 1995-04-19 Euro Celtique Sa Oral morphine-6-glucuronide compositions
ES2201482T3 (es) * 1997-04-14 2004-03-16 Ufc Limited Derivados de la morfina.
PL342189A1 (en) * 1998-02-02 2001-05-21 Cenes Ltd Method of glycosiding 4,5-epoxymorphinan-6-oles
WO1999064430A2 (en) 1998-06-06 1999-12-16 Cenes Limited Morphine-6-glucuronide synthesis
DE10161963A1 (de) * 2001-12-17 2003-07-03 Johannes Schuetz 6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung
DE10229842A1 (de) * 2002-07-03 2004-02-05 Helmut Prof. Dr. Schmidhammer Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
GB0218811D0 (en) * 2002-08-14 2002-09-18 Cenes Ltd Salts of morphine-6-glucuronide
FR2864082B1 (fr) * 2003-12-22 2006-03-10 Synt Em Nouveau derive de la morphine-6-glucuronide, composition pharmaceutique le contenant et son utilisation pour le traitement de la douleur
DK1758452T3 (en) * 2004-05-28 2017-05-01 Human Biomolecular Res Inst METABOLIC STABLE ANALGETICS AND Painkillers
FR2907121B1 (fr) * 2006-10-12 2012-05-04 Neorphys Nouveaux derives morphiniques

Also Published As

Publication number Publication date
KR20110091536A (ko) 2011-08-11
EP2376511B1 (fr) 2014-03-12
ZA201104389B (en) 2012-09-26
EP2376511A2 (fr) 2011-10-19
CA2746701A1 (fr) 2010-06-17
FR2939796B1 (fr) 2010-12-17
UA104445C2 (uk) 2014-02-10
FR2939796A1 (fr) 2010-06-18
NZ593340A (en) 2012-12-21
US20110275580A1 (en) 2011-11-10
TW201026313A (en) 2010-07-16
IL213380A0 (en) 2011-07-31
SG172070A1 (en) 2011-07-28
HK1163109A1 (en) 2012-09-07
EA201170791A1 (ru) 2012-01-30
AR074578A1 (es) 2011-01-26
TN2011000277A1 (fr) 2012-12-17
ES2470684T3 (es) 2014-06-24
BRPI0923368A2 (pt) 2019-09-24
NI201100113A (es) 2011-12-15
AU2009326907B2 (en) 2016-05-26
US8440634B2 (en) 2013-05-14
MY153779A (en) 2015-03-13
JP2012511552A (ja) 2012-05-24
JP5616355B2 (ja) 2014-10-29
CO6382159A2 (es) 2012-02-15
CN102317302B (zh) 2014-02-12
SV2011003937A (es) 2012-01-20
WO2010067008A2 (fr) 2010-06-17
CN102317302A (zh) 2012-01-11
ECSP11011107A (es) 2011-07-29
AU2009326907A1 (en) 2011-06-30
MX2011006251A (es) 2011-11-18
PE20120231A1 (es) 2012-04-04
WO2010067008A3 (fr) 2011-07-07
CR20110317A (es) 2011-10-18
CL2011001401A1 (es) 2011-10-28
MA32954B1 (fr) 2012-01-02
HN2011001614A (es) 2014-03-03
IL213380A (en) 2014-02-27

Similar Documents

Publication Publication Date Title
EA201001017A1 (ru) 3h-[1,2,3]триазоло[4,5-d]пиримидиновые соединения, их применение в качестве ингибиторов киназы mtor и киназы pi3 и их синтезы
MX2011012337A (es) Nuevos derivados de pirimidina y su uso en el tratamiento de cancer y de otras enfermedades.
BRPI0511967B8 (pt) derivados de 5-amino-2,4,7-trioxo-3,4,7,8-tetrahidro-2h-pirido[2,3-d] pirimidina, seu uso e composição farmacêutica que os compreende
TN2013000293A1 (en) Derivatives of azaindazole or diazaindazole type as medicament
GEP20156417B (en) Pyrrolo [2,3-d] pyrimidine derivatives as inhibitors of tropomyosin-related kinases
EA201070929A1 (ru) ФУРО- И ТИЕНО[3,2-c]ПИРИДИНЫ
NZ592608A (en) Benzoxazole kinase inhibitors and methods of use
EA200970510A1 (ru) Гетеромоноциклическое соединение и его применение
DK1678166T3 (da) Proteinkinaseinhibitorer
PE20091211A1 (es) Derivados de pirazolopirimidina como moduladores de pde9a
AR057531A1 (es) Pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina y composicion farmaceutica
BR112014007310A2 (pt) 3-pirimidin-4-il-oxazolidin-2-onas como inibidores de idh mutante
MA37405A1 (fr) Composés hétérocyclyle
EA201101671A1 (ru) Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина
UY30411A1 (es) Derivados sustituidos del acetato de 2,3,4,-tetrahidroimidazo-[1,5-a]-pirimidin-6-amina, composiciones farmacéuticas y aplicaciones
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
UA110347C2 (uk) ПОХІДНІ 6-ЦИКЛОАЛКІЛ-1,5-ДИГІДРОПІРАЗОЛО[3,4-d]ПІРИМІДИН-4-ОНУ І ЇХ ЗАСТОСУВАННЯ ЯК ІНГІБІТОРІВ PDE9A
MX2012007273A (es) Pteridinonas como inhibidores de la quinasa tipo polo.
AU2012258977A8 (en) Inhibitors of LRRK2 kinase activity
MX355164B (es) Derivados de 3,4-dihidro-2h-pirido[1,2-a]pirazin-1,6-diona sustituidos utiles para el tratamiento de la enfermedad de alzheimer (inter alia).
DK2041133T3 (da) Derivater af imadazol [1,2-A] pyridine-2-carboxamider, fremstilling deraf og anvendelse deraf i terapeutik
BRPI0409314A (pt) derivados de 2-aminopirimidina e seu uso médico
EA201070841A1 (ru) НОВЫЕ ПИРАЗОЛО[3,4-d]ПИРИМИДИНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ПРОТИВОРАКОВЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ
RU2011150826A (ru) ГИДРОХЛОРИД ((1S,2S,4R)-4-{4-[(1S)-2,3-ДИГИДРО-1Н-ИНДЕН-1-ИЛАМИНО]-7Н-ПИРРОЛО [2,3-d]ПИРИМИДИН-7-ИЛ}-2-ГИДРОКСИЦИКЛОПЕНТИЛ)МЕТИЛ СУЛЬФАМАТА
ITBO20110012A1 (it) Composizioni farmaceutiche comprendenti rifaximina e loro uso.